Twinrix Related Published Studies
Well-designed clinical trials related to Twinrix (Hepatitis A Vaccine / Hepatitis B Vaccine)
Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens. [2011.04]
Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers. [2011.04]
Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years. [2011.03]
A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients. [2010.10]
Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents. [2010.08.23]
Predictors of hepatitis knowledge improvement among methadone maintained clients enrolled in a hepatitis intervention program. [2010.08]
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. [2010.06.17]
Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States. [2010.06]
Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. [2009.01]
A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire. [2008.05.23]
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years. [2008.04.15]
Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents. [2008.03.25]
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. [2008.03.04]
Positive Impact of a Shelter-based Hepatitis B Vaccine Program in Homeless Baltimore Children and Adolescents. [2008.03]
Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines. [2008.01.30]
Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth. [2008.01.30]
Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults. [2008.01]
One arm or two? Concurrent administration of meningococcal C conjugate and hepatitis B vaccines in pre-teens. [2008.01]
[A randomized controlled trial on effect of hepatitis B immune globulin in preventing hepatitis B virus transmission from mothers to infants] [2008.01]
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. [2007.12.12]
Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer. [2007.12]
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. [2007.11]
Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccine. [2007.10.23]
Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine. [2007.10]
Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant. [2007.10]
Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. [2007.09]
Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure. [2007.09]
Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial. [2007.09]
Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years. [2007.08]
Cellular and humoral immune response to a third generation hepatitis B vaccine. [2007.08]
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months. [2007.08]
Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. [2007.07]
Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. [2007.06.14]
Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults. [2007.05]
Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. [2006.06.29]
Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. [2005.10.17]
A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. [2005.04.22]
Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. [2004.03]
Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view. [2004]
[Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents.] [2003.10]
Hepatitis A and B vaccination in a sexually transmitted disease clinic for men who have sex with men. [2003.09]
Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years. [2002.06.07]
Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in healthy Chilean subjects. [2002.06]
Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children. [2002.05.15]
Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity. [2002.05]
A new accelerated vaccination schedule for rapid protection against hepatitis A and B. [2002.01.15]
A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines. [2002.01]
Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study. [2001.09.14]
A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. [2001.09.14]
Randomized controlled trial of concurrent hepatitis A and B vaccination. [2001.02]
Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix. [2000.12.08]
Different HBs antibody versus lymphoproliferative responses after application of a monovalent (hepatitis B) or combined (hepatitis A + hepatitis B) vaccine. [2000.12]
Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults. [2000.10.15]
Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines. [2000.01.06]
Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years. [1999.12]
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. [1999.12]
A two dose combined hepatitis A and B vaccine in Chinese youngsters. [1999.09]
Immunogenicity and reactogenicity of a combined hepatitis A-hepatitis B vaccine in adolescents. [1998.04]
Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. [1996.10]
Protection against hepatitis A by an inactivated vaccine. [1994.05.04]
Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule. [1994.05]
A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. [1994.05]
Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. [1993.09]
Simultaneous vaccination against hepatitis A and B: results of a controlled study. [1992]
Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile. [1992]
Well-designed clinical trials possibly related to Twinrix (Hepatitis A Vaccine / Hepatitis B Vaccine)
Sleep after vaccination boosts immunological memory. [2011.07.01]
Predictors of HAV/HBV vaccination completion among methadone maintenance clients. [2010.04]
Feasibility of completing an accelerated vaccine series for homeless adults. [2009.09]
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. [2008.05]
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individuals. [2008.02.20]
Analgesic properties of oral sucrose during routine immunizations at 2 and 4 months of age. [2008.02]
Adverse reactions to simultaneous influenza and pneumococcal conjugate vaccinations in children: randomized double-blind controlled trial. [2008.01.22]
Primary vaccination with a new heptavalent DTPw-HBV/Hib-Neisseria meningitidis serogroups A and C combined vaccine is well tolerated. [2008.01]
The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents. [2007.12.05]
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. [2007.11.03]
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians. [2007.10.17]
Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines. [2007.10]
DTPa-HBV-IPV vaccine for primary vaccination of infants. [2007.09]
Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. [2007.08]
Acetaminophen and ibuprofen for prevention of adverse reactions associated with childhood immunization. [2007.07]
Other research related to Twinrix (Hepatitis A Vaccine / Hepatitis B Vaccine)
[Evaluation on the effect of immunization and safety of live attenuated and
inactivated hepatitis A vaccine in China]. [Article in Chinese] [2013]
A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix((R)) in subjects aged 11-17 years: An open, randomised, controlled trial. [2011.11.19]
Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose. [2011.11.08]
Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age. [2011.08]
Unmet needs among people reported with hepatitis C, New York City. [2011.07]
A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. [2011.05.19]
[Prevention of virus hepatitis A to E]. [2011.03]
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. [2011.01]
Antibody persistence and immune memory 4 years post-vaccination with combined
hepatitis A and B vaccine in adults aged over 40 years. [2011]
Importance of hepatitis vaccination in patients with chronic liver disease. [2010.12]
Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals. [2010.12]
Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients. [2010.11]
Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program. [2010.10]
Quality of care in patients with chronic hepatitis C virus infection: a cohort study. [2010.08.17]
[Viral hepatitis--trends] [2010.04]
[Safety and immunogenicity of combined hepatitis A and hepatitis B vaccine according to 0 and 6 months schedule in healthy children] [2010.02]
Current issues in the management of paediatric viral hepatitis. [2010.01]
Randomized trial to determine safety and immunogenicity of two strategies for
hepatitis B vaccination in healthy urban adolescents in the United States. [2010]
Predictors of hepatitis knowledge improvement among methadone maintained clients
enrolled in a hepatitis intervention program. [2010]
Advances in viral hepatitis: 50 years of Australian gastroenterology. [2009.10]
Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis. [2009.09]
|
